U.S. women’s gymnastics team to be featured on limited-edition Corn Flakes boxes
BATTLE CREEK, Mich. — Kellogg’s is honoring the U.S. women’s gymnastics team by debuting limited-edition boxes of Corn Flakes this fall.
The box will feature team members Gabby Douglas, McKayla Maroney, Aly Raisman, Kyla Ross and Jordyn Wieber, who collectively won the gold medal in the women’s team competition at the 2012 Olympic Games in London. Kellogg’s, an official sponsor of the United States Olympic Committee and USA Gymnastics, said the limited-edition boxes will hit retail shelves this fall.
Kellogg’s announced last week that a limited-edition box featuring team member Gabby Douglas also will be rolled out this fall.
Innovative Product Concepts to introduce Medicine Safe
HILLSBOROUGH, N.J. — Innovative Product Concepts is introducing a new product that’s designed to keep prescriptions and over-the-counter medications organized and secure.
The company said Medicine Safe is constructed with a high integrity ABS/glass filled nylon composite material with a steel liner sandwiched in between and can accommodate prescription bottles that are up to 4 in. tall. Medicine Safe also keeps medicine secure with its patent pending locking mechanism that deploys two steel "double throw" locking bolts. The Medicine Safe can rest inside a standard medicine cabinet or can be securely mounted by using any combination of six prepositioned mounting points, the company said.
Carrying a suggested retail price of $69.95, Medicine Safe will be sold online at Target.com and Sharper Image.
Bristol-Myers Squibb purchase of Amylin mostly complete, company says
NEW YORK — Bristol-Myers Squibb has bought a majority stake in drug maker Amylin Pharmaceuticals, Bristol said Wednesday.
The New York-based drug maker said that 140.5 million shares of Amylin had been put up for sale at $31 per share, and that it now owned 85.55% of the San Diego-based company. Bristol said it planned to acquire the rest of Amylin’s shares Wednesday as well.
Bristol announced its intention to buy Amylin for $5.3 billion in early July. The total value of the acquisition is about $7 billion, including $1.7 billion in Amylin’s contractual payment and debt obligations.